Vaginal News and Research

RSS

Women more likely to experience UI following vaginal delivery

Women are nearly three times more likely to experience urinary incontinence for more than 10 years following a vaginal delivery rather than a caesarean section, finds new research at the Sahlgrenska Academy at the University of Gothenburg, Sweden.

26 Mar 2012

CBT, PE can ameliorate treatment-induced menopausal symptoms in breast cancer patients

Researchers from The Netherlands have found that the menopausal symptoms caused by giving chemotherapy or hormonal therapy to younger women with breast cancer can be ameliorated considerably through the use of cognitive behavioural therapy (CBT) and physical exercise.

23 Mar 2012

TGA clears Bioline's illumigene Group B Streptococcus test

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.

22 Mar 2012

Deletion of Hms1 protein inhibits Candida albicans infection

Scientists at the University of Toronto have found a molecular mechanism that plays a key role in the transition of Candida albicans yeast into disease-causing fungus-one of the leading causes of hospital-acquired infection.

17 Mar 2012

Researchers design new version of labor-tracking tool for pregnant women

Researchers have designed a new version of a labor-tracking tool for pregnant women that they predict could reduce the use of hormonal intervention during labor and lower the number of cesarean sections performed on low-risk, first-time mothers.

15 Mar 2012

Planned elective repeat cesarean lowers risk of serious complications

A major study led by the University of Adelaide has found that women who have had one prior cesarean can lower the risk of death and serious complications for their next baby - and themselves - by electing to have another cesarean.

14 Mar 2012

Va. Gov. signs pre-abortion ultrasound bill

Virginia Gov. Bob McDonnell has signed a contentious bill mandating women who want an abortion get an ultrasound before the procedure.

9 Mar 2012

Columbia Labs fourth quarter total net revenues decrease to $6.4M

Columbia Laboratories, Inc. today reported financial results for the three- and twelve-month periods ended December 31, 2011.

8 Mar 2012

New clinical trial: Pycnogenol improves signs and symptoms of menopause

Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects.

7 Mar 2012

Ga. House passes bill restricting abortion to limit fetal pain

The legislation would cut six weeks from the time women can have an elective abortion, the Atlanta Journal-Constitution reports.

2 Mar 2012

Treatment with vitamin D reduces size of uterine fibroids

Treatment with vitamin D reduced the size of uterine fibroids in laboratory rats predisposed to developing the benign tumors, reported researchers funded by the National Institutes of Health.

2 Mar 2012

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.

29 Feb 2012

Viewpoints: 'Romney's rebound,' Va. lawmakers' ultrasound vote, Kennedy's not sole interpreters of Senator's legacy

But Mr. Romney also improved his case for his own candidacy, stressing a reform agenda as much as his business biography. In the final days in particular, he pressed his new plan for a 20 percent across-the-board income tax cut, as well as Medicare reform. He stressed his ability to revive the economy, which remains the dominant issue even among conservatives, despite the prominence of social issues in the last week.

29 Feb 2012

First Edition: February 29, 2012

Today's headlines include reports on yesterday's GOP presidential primary elections and how health policy played a role in some of the rhetoric.

29 Feb 2012

Scientists discover new pathway necessary for infection to occur with N. gonorrhoeae

Researchers from Boston University School of Medicine (BUSM) have for the first time identified a novel pathway that is necessary for infection to occur with the pathogen Neisseria gonorrhoeae, which is responsible for the second most common infectious disease worldwide, gonorrhea.

28 Feb 2012

Abortion legislation making noise at state capitols

A host of abortion legislation proposals in state capitols around America - ranging from requiring Colorado doctors with religious objections give patients notice to mandated insurance coverage of abortion in Washington - are making news.

28 Feb 2012

FDA issues complete response letter for Watson's progesterone vaginal gel 8% NDA

Watson Pharmaceuticals, Inc. and Columbia Laboratories, Inc. today confirmed that, as expected, Watson has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA 22-139) for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy.

27 Feb 2012

First Edition: February 27, 2012

Among today's health policy headlines, a new Politico poll highlights the deep divide in public opinion that exists regarding the repeal of the health law.

27 Feb 2012

Va. lawmakers backdown from requiring invasive, pre-abortion ultrasound

Virginia lawmakers backed off a proposal Wednesday to require women seeking abortions get an transvaginal ultrasound after Gov. Bob McDonnell said he wouldn't support it. Virginia House lawmakers instead approved an amended bill requiring only an external ultrasound.

24 Feb 2012

International Microbicides Conference to take place from April 15-18

The biennial International Microbicides Conference is the premier gathering for those working on new approaches to HIV prevention and this year's conference in Sydney, Australia will place a strong emphasis on the role of community in both research and implementation of scientific findings. The conference will take place from April 15-18 at the Sydney Exhibition and Conference Centre located on the Darling Harbour waterfront.

23 Feb 2012